JP2023504201A5 - - Google Patents

Info

Publication number
JP2023504201A5
JP2023504201A5 JP2022534352A JP2022534352A JP2023504201A5 JP 2023504201 A5 JP2023504201 A5 JP 2023504201A5 JP 2022534352 A JP2022534352 A JP 2022534352A JP 2022534352 A JP2022534352 A JP 2022534352A JP 2023504201 A5 JP2023504201 A5 JP 2023504201A5
Authority
JP
Japan
Prior art keywords
acid sequence
protein
promoter
vector
active fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022534352A
Other languages
English (en)
Japanese (ja)
Other versions
JP7701359B2 (ja
JP2023504201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/063319 external-priority patent/WO2021113642A1/en
Publication of JP2023504201A publication Critical patent/JP2023504201A/ja
Publication of JP2023504201A5 publication Critical patent/JP2023504201A5/ja
Priority to JP2025104155A priority Critical patent/JP2025126223A/ja
Application granted granted Critical
Publication of JP7701359B2 publication Critical patent/JP7701359B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022534352A 2019-12-05 2020-12-04 変形性関節症の治療方法 Active JP7701359B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025104155A JP2025126223A (ja) 2019-12-05 2025-06-19 変形性関節症の治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962944027P 2019-12-05 2019-12-05
US62/944,027 2019-12-05
PCT/US2020/063319 WO2021113642A1 (en) 2019-12-05 2020-12-04 Methods for treating osteoarthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025104155A Division JP2025126223A (ja) 2019-12-05 2025-06-19 変形性関節症の治療方法

Publications (3)

Publication Number Publication Date
JP2023504201A JP2023504201A (ja) 2023-02-01
JP2023504201A5 true JP2023504201A5 (enExample) 2023-12-11
JP7701359B2 JP7701359B2 (ja) 2025-07-01

Family

ID=76222269

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022534352A Active JP7701359B2 (ja) 2019-12-05 2020-12-04 変形性関節症の治療方法
JP2025104155A Pending JP2025126223A (ja) 2019-12-05 2025-06-19 変形性関節症の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025104155A Pending JP2025126223A (ja) 2019-12-05 2025-06-19 変形性関節症の治療方法

Country Status (8)

Country Link
US (1) US20230024183A1 (enExample)
EP (1) EP4069313A4 (enExample)
JP (2) JP7701359B2 (enExample)
KR (1) KR20220119056A (enExample)
CN (1) CN115515645A (enExample)
AU (1) AU2020398637A1 (enExample)
CA (1) CA3160033A1 (enExample)
WO (1) WO2021113642A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250000512A (ko) 2023-06-27 2025-01-03 동신대학교산학협력단 요오드아세트산 나트륨 유도 골관절염에 양릉천과 현종 혈위를 자극하는 침습형 레이저침을 이용한 치료 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3548999A (en) * 1998-04-03 1999-10-25 Chiron Corporation Use of igfi for treating articular cartilage disorders
AU4572899A (en) * 1998-06-16 2000-01-05 Biogen, Inc. Variant type ii tgf-beta receptor fusion proteins and methods
TW200936156A (en) * 2008-01-28 2009-09-01 Novartis Ag Methods and compositions using Klotho-FGF fusion polypeptides
NZ590667A (en) * 2008-07-02 2013-01-25 Emergent Product Dev Seattle Tgf-b antagonist multi-target binding proteins
MX2018014256A (es) * 2016-05-20 2019-08-16 Harvard College Metodos de terapia genica para enfermedades y condiciones relacionadas con la edad.
EP3464608A4 (en) * 2016-06-02 2020-01-29 Klotho Therapeutics, Inc. THERAPEUTIC RECOMBINANT KLOTHO PROTEINS, COMPOSITIONS AND METHODS THEREFOR
AU2017363321B2 (en) * 2016-11-22 2023-09-28 Klotho Therapeutics, Inc. Novel recombinant Klotho proteins and compositions and methods involving the same

Similar Documents

Publication Publication Date Title
JP2022033855A5 (enExample)
JP2025078652A5 (enExample)
JP2019519221A5 (enExample)
IL299325B2 (en) Acid-alpha glucosidase variants and uses thereof
HRP20221542T1 (hr) Pripravci i postupci za povećanje ili pojačanje transdukcije vektora genske terapije i za uklanjanje ili smanjenje imunoglobulina
JP2021511803A5 (enExample)
JP2022523679A5 (enExample)
EP2037892B1 (en) Modified factor viii and factor ix genes and vectors for gene therapy
JP2022508182A5 (enExample)
JP2022549380A5 (enExample)
JP2009526067A5 (enExample)
JP2022535749A5 (enExample)
RU2021102893A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
JP2021513999A5 (enExample)
JP2022544004A5 (enExample)
JP2022524434A5 (enExample)
JP2018526003A (ja) イヌの癌を治療するためのキメラaav−抗vegf
JP2017529395A5 (enExample)
JP2022541070A5 (enExample)
CN121575014A (zh) 成纤维细胞生长因子23相关的低磷酸盐血症的基因治疗
WO2020208032A1 (en) Hybrid promoters for muscle expression
JP2022551744A5 (enExample)
JP2021520811A5 (enExample)
JP2021520232A5 (enExample)
JP2020509786A5 (enExample)